Prevail Therapeutics
A biotechnology company.
HQ location
New York City, United States
Website
Launch date
Employees
Enterprise value
$1.0b
Share price
$23.00 PRVL
Recent deals
loading funding rounds…
Abbvie Biotech Ventures(exited)
Alexandria Venture Investments(exited)
Boxer Capital(exited)
EcoR1 Capital(exited)
Omega Funds(exited)
OrbiMed(exited)
RA Capital Management(exited)
Pontifax Funds(exited)
| USD | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
